1. SALL4: An Intriguing Therapeutic Target in Cancer Treatment
    Shiva Moein et al, 2022, Cells CrossRef
  2. Tissue-guided LASSO for prediction of clinical drug response using preclinical samples
    Edward W. Huang et al, 2020, PLOS Computational Biology CrossRef
  3. The new advance of SALL4 in cancer: Function, regulation, and implication
    Fatma A. Abouelnazar et al, 2023, Journal of Clinical Laboratory Analysis CrossRef
  4. ALDH1 and SALL4 Expression in Cell Block Samples from Patients with Lung Adenocarcinoma and Malignant Pleural Effusion
    Tomohiro Kanayama et al, 2021, Diagnostics CrossRef
  5. Overexpression of Sal-like protein 4 in head and neck cancer: epigenetic effects and clinical correlations
    Kiyoshi Misawa et al, 2020, Cellular Oncology CrossRef
  6. SALL4 promotes gastric cancer progression through activating CD44 expression
    X Yuan et al, 2016, Oncogenesis CrossRef
  7. SALL4 induces radioresistance in nasopharyngeal carcinoma via the ATM/Chk2/p53 pathway
    Xin Nie et al, 2019, Cancer Medicine CrossRef
  8. The diagnostic and prognostic value of SALL4 in hepatoblastoma
    Shengmei Zhou et al, 2016, Histopathology CrossRef
  9. MicroRNA-98 Plays a Suppressive Role in Non-Small Cell Lung Cancer Through Inhibition of SALL4 Protein Expression
    Wenliang Liu et al, 2017, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef

  10. Sal-Like Protein 4 Transcription Factor: A Significant Diagnostic Biomarker Involved in Childhood ALL Resistance and Relapse


    Farzaneh Ohadi et al, 2020, Cancer Management and Research CrossRef
  11. Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non‐small cell lung cancer
    Yu Wakabayashi et al, 2021, Cancer Science CrossRef
  12. Up-Regulation of SALL4 Is Associated With Survival and Progression via Putative WNT Pathway in Gastric Cancer
    Yang Yang et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
  13. Knockdown of SALL4 inhibits the proliferation and reverses the resistance of MCF-7/ADR cells to doxorubicin hydrochloride
    Yuan-Yuan Chen et al, 2016, BMC Molecular Biology CrossRef
  14. Upregulation of SALL4 by EGFR activation regulates the stemness of CD44-positive lung cancer
    Wenjing Du et al, 2018, Oncogenesis CrossRef
  15. SALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance
    Boshu Sun et al, 2022, International Journal of Molecular Sciences CrossRef
  16. SALL4 promotes glycolysis and chromatin remodeling via modulating HP1α-Glut1 pathway
    J Kim et al, 2017, Oncogene CrossRef
  17. SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts
    Marie Kroemer et al, 2018, OncoImmunology CrossRef
  18. SALL4 and microRNA: The Role of Let-7
    Jun Liu et al, 2021, Genes CrossRef
  19. SALL Proteins; Common and Antagonistic Roles in Cancer
    Claudia Álvarez et al, 2021, Cancers CrossRef
  20. Role of SALL4 in HER2+ Breast Cancer Progression: Regulating PI3K/AKT Pathway
    Birlipta Pattanayak et al, 2022, International Journal of Molecular Sciences CrossRef